These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32457139)

  • 21. A comparative study of CSF neurofilament light and heavy chain protein in MS.
    Kuhle J; Plattner K; Bestwick JP; Lindberg RL; Ramagopalan SV; Norgren N; Nissim A; Malaspina A; Leppert D; Giovannoni G; Kappos L
    Mult Scler; 2013 Oct; 19(12):1597-603. PubMed ID: 23529999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis.
    Comabella M; Fernández M; Martin R; Rivera-Vallvé S; Borrás E; Chiva C; Julià E; Rovira A; Cantó E; Alvarez-Cermeño JC; Villar LM; Tintoré M; Montalban X
    Brain; 2010 Apr; 133(Pt 4):1082-93. PubMed ID: 20237129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression.
    Albanese M; Zagaglia S; Landi D; Boffa L; Nicoletti CG; Marciani MG; Mandolesi G; Marfia GA; Buttari F; Mori F; Centonze D
    J Neuroinflammation; 2016 Feb; 13():36. PubMed ID: 26863878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokine and immune cell profiling in the cerebrospinal fluid of patients with neuro-inflammatory diseases.
    Lepennetier G; Hracsko Z; Unger M; Van Griensven M; Grummel V; Krumbholz M; Berthele A; Hemmer B; Kowarik MC
    J Neuroinflammation; 2019 Nov; 16(1):219. PubMed ID: 31727097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
    Bettcher BM; Johnson SC; Fitch R; Casaletto KB; Heffernan KS; Asthana S; Zetterberg H; Blennow K; Carlsson CM; Neuhaus J; Bendlin BB; Kramer JH
    J Alzheimers Dis; 2018; 62(1):385-397. PubMed ID: 29439331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Parameters That Distinguish Multiple Sclerosis Patients from Patients with Other Neurological Disorders at Presentation.
    Mouzaki A; Rodi M; Dimisianos N; Emmanuil A; Kalavrizioti D; Lagoudaki R; Grigoriadis NC; Papathanasopoulos P
    PLoS One; 2015; 10(8):e0135434. PubMed ID: 26317430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cytoimmunological profile of cerebrospinal fluid in diagnosis of multiple sclerosis].
    Caudie C; Birouk AM; Bancel J; Claudy D; Gignoux L; Vukusic S; Confavreux C
    Pathol Biol (Paris); 2005 Mar; 53(2):68-74. PubMed ID: 15708649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis.
    Danilov AI; Andersson M; Bavand N; Wiklund NP; Olsson T; Brundin L
    J Neuroimmunol; 2003 Mar; 136(1-2):112-8. PubMed ID: 12620649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis has a distinct lipid signature in plasma and cerebrospinal fluid.
    Oliveira EML; Montani DA; Oliveira-Silva D; Rodrigues-Oliveira AF; Matas SLA; Fernandes GBP; Silva IDCGD; Lo Turco EG
    Arq Neuropsiquiatr; 2019; 77(10):696-704. PubMed ID: 31664345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive phenotyping in multiple sclerosis: discovery based proteomics and the current understanding of putative biomarkers.
    O'Connor KC; Roy SM; Becker CH; Hafler DA; Kantor AB
    Dis Markers; 2006; 22(4):213-25. PubMed ID: 17124343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High performance of cerebrospinal fluid immunoglobulin G analysis for diagnosis of multiple sclerosis.
    Gamraoui S; Mathey G; Debouverie M; Malaplate C; Anxionnat R; Guillemin F; Epstein J
    J Neurol; 2019 Apr; 266(4):902-909. PubMed ID: 30707357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential Biomarkers Associated with Multiple Sclerosis Pathology.
    Mathur D; Mishra BK; Rout S; Lopez-Iranzo FJ; Lopez-Rodas G; Vallamkondu J; Kandimalla R; Casanova B
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteomics characterization of extracellular vesicles sorted by flow cytometry reveals a disease-specific molecular cross-talk from cerebrospinal fluid and tears in multiple sclerosis.
    Pieragostino D; Lanuti P; Cicalini I; Cufaro MC; Ciccocioppo F; Ronci M; Simeone P; Onofrj M; van der Pol E; Fontana A; Marchisio M; Del Boccio P
    J Proteomics; 2019 Jul; 204():103403. PubMed ID: 31170500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
    Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
    Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
    Salvisberg C; Tajouri N; Hainard A; Burkhard PR; Lalive PH; Turck N
    Proteomics Clin Appl; 2014 Apr; 8(3-4):185-94. PubMed ID: 24488530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis.
    Komori M; Blake A; Greenwood M; Lin YC; Kosa P; Ghazali D; Winokur P; Natrajan M; Wuest SC; Romm E; Panackal AA; Williamson PR; Wu T; Bielekova B
    Ann Neurol; 2015 Jul; 78(1):3-20. PubMed ID: 25808056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free Kappa light chains in neuroinflammatory disorders: Complement rather than substitute?
    Bayart JL; Muls N; van Pesch V
    Acta Neurol Scand; 2018 Oct; 138(4):352-358. PubMed ID: 29900542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma biomarkers discriminate clinical forms of multiple sclerosis.
    Tejera-Alhambra M; Casrouge A; de Andrés C; Seyfferth A; Ramos-Medina R; Alonso B; Vega J; Fernández-Paredes L; Albert ML; Sánchez-Ramón S
    PLoS One; 2015; 10(6):e0128952. PubMed ID: 26039252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.
    Lycke J; Zetterberg H
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1143-1153. PubMed ID: 29090607
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omics-Based Approach Reveals Complement-Mediated Inflammation in Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids (CLIPPERS).
    Blaabjerg M; Hemdrup AL; Drici L; Ruprecht K; Garred P; Höftberger R; Kristensen BW; Kondziella D; Sejbaek T; Hansen SW; Nielsen HH; Jensen P; Meyer M; Paul F; Lassmann H; Larsen MR; Illes Z
    Front Immunol; 2018; 9():741. PubMed ID: 29740431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.